Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
Clinical trial NCT02410551 · TERMINATED
Trial details
- NCT number
- NCT02410551
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2017-01-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.